- Home
- UPC vs ADIL Comparison
UPC vs ADIL Comparison
Compare UPC & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPC
- ADIL
- Stock Information
- Founded
- UPC 1998
- ADIL 2010
- Country
- UPC China
- ADIL United States
- Employees
- UPC N/A
- ADIL N/A
- Industry
- UPC Biotechnology: Pharmaceutical Preparations
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- UPC Health Care
- ADIL Health Care
- Exchange
- UPC Nasdaq
- ADIL Nasdaq
- Market Cap
- UPC 6.6M
- ADIL 6.5M
- IPO Year
- UPC 2021
- ADIL 2018
- Fundamental
- Price
- UPC $0.14
- ADIL $1.06
- Analyst Decision
- UPC
- ADIL Strong Buy
- Analyst Count
- UPC 0
- ADIL 1
- Target Price
- UPC N/A
- ADIL $8.00
- AVG Volume (30 Days)
- UPC 803.8K
- ADIL 222.2K
- Earning Date
- UPC 01-01-0001
- ADIL 11-13-2024
- Dividend Yield
- UPC N/A
- ADIL N/A
- EPS Growth
- UPC N/A
- ADIL N/A
- EPS
- UPC N/A
- ADIL N/A
- Revenue
- UPC $26,725,919.00
- ADIL N/A
- Revenue This Year
- UPC N/A
- ADIL N/A
- Revenue Next Year
- UPC N/A
- ADIL N/A
- P/E Ratio
- UPC N/A
- ADIL N/A
- Revenue Growth
- UPC N/A
- ADIL N/A
- 52 Week Low
- UPC $0.12
- ADIL $0.77
- 52 Week High
- UPC $4.32
- ADIL $4.17
- Technical
- Relative Strength Index (RSI)
- UPC 20.65
- ADIL 52.82
- Support Level
- UPC $0.22
- ADIL $0.98
- Resistance Level
- UPC $0.29
- ADIL $1.28
- Average True Range (ATR)
- UPC 0.03
- ADIL 0.07
- MACD
- UPC 0.02
- ADIL 0.00
- Stochastic Oscillator
- UPC 10.30
- ADIL 29.03
About UPC Universe Pharmaceuticals Inc.
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.